|
1
|
Domper Arnal MJ, Ferrández Arenas Á and
Lanas Arbeloa Á: Esophageal cancer: Risk factors, screening and
endoscopic treatment in Western and Eastern countries. World J
Gastroenterol. 21:7933–7943. 2015. View Article : Google Scholar
|
|
2
|
Tachimori Y, Ozawa S, Numasaki H,
Fujishiro M, Matsubara H, Oyama T, Shinoda M, Toh Y, Udagawa H and
Uno T: Comprehensive Registry of Esophageal Cancer in Japan, 2008.
Esophagus. 12:130–157. 2015. View Article : Google Scholar
|
|
3
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al CROSS Group:
Preoperative chemoradiotherapy for esophageal or junctional cancer.
N Engl J Med. 366:2074–2084. 2012. View Article : Google Scholar
|
|
4
|
Ando N, Kato H, Igaki H, Shinoda M, Ozawa
S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar
|
|
5
|
Abbassi-Ghadi N, Kumar S, Huang J, Goldin
R, Takats Z and Hanna GB: Metabolomic profiling of
oesophago-gastric cancer: A systematic review. Eur J Cancer.
49:3625–3637. 2013. View Article : Google Scholar
|
|
6
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47. 2016.
View Article : Google Scholar
|
|
7
|
Kami K, Fujimori T, Sato H, Sato M,
Yamamoto H, Ohashi Y, Sugiyama N, Ishihama Y, Onozuka H, Ochiai A,
et al: Metabolomic profiling of lung and prostate tumor tissues by
capillary electrophoresis time-of-flight mass spectrometry.
Metabolomics. 9:444–453. 2013. View Article : Google Scholar
|
|
8
|
Hirayama A, Kami K, Sugimoto M, Sugawara
M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, et
al: Quantitative metabolome profiling of colon and stomach cancer
microenvironment by capillary electrophoresis time-of-flight mass
spectrometry. Cancer Res. 69:4918–4925. 2009. View Article : Google Scholar
|
|
9
|
Ikeda A, Nishiumi S, Shinohara M, Yoshie
T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, et
al: Serum metabolomics as a novel diagnostic approach for
gastrointestinal cancer. Biomed Chromatogr. 26:548–558. 2012.
View Article : Google Scholar
|
|
10
|
Xu J, Chen Y, Zhang R, Song Y, Cao J, Bi
N, Wang J, He J, Bai J, Dong L, et al: Global and targeted
metabolomics of esophageal squamous cell carcinoma discovers
potential diagnostic and therapeutic biomarkers. Mol Cell
Proteomics. 12:1306–1318. 2013. View Article : Google Scholar
|
|
11
|
Zhang X, Xu L, Shen J, Cao B, Cheng T,
Zhao T, Liu X and Zhang H: Metabolic signatures of esophageal
cancer: NMR-based metabolomics and UHPLC-based focused metabolomics
of blood serum. Biochim Biophys Acta. 1832:1207–1216. 2013.
View Article : Google Scholar
|
|
12
|
Ma H, Hasim A, Mamtimin B, Kong B, Zhang
HP and Sheyhidin I: Plasma free amino acid profiling of esophageal
cancer using high-performance liquid chromatography spectroscopy.
World J Gastroenterol. 20:8653–8659. 2014. View Article : Google Scholar
|
|
13
|
Yang Y, Wang L, Wang S, Liang S, Chen A,
Tang H, Chen L and Deng F: Study of metabonomic profiles of human
esophageal carcinoma by use of high-resolution magic-angle spinning
1H NMR spectroscopy and multivariate data analysis. Anal Bioanal
Chem. 405:3381–3389. 2013. View Article : Google Scholar
|
|
14
|
Wang L, Chen J, Chen L, Deng P, Bu Q,
Xiang P, Li M, Lu W, Xu Y, Lin H, et al: 1H-NMR based metabonomic
profiling of human esophageal cancer tissue. Mol Cancer. 12:252013.
View Article : Google Scholar
|
|
15
|
Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H,
Wang Q and Shen X: Metabolomic study for diagnostic model of
oesophageal cancer using gas chromatography/mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci. 877:3111–3117. 2009.
View Article : Google Scholar
|
|
16
|
The Japan Eshophageal Society: Japanese
Classification of Esophageal Cancer 11th edition. Esophagus. Nov
10–2016.Epub ahead of print.
|
|
17
|
Ohashi Y, Hirayama A, Ishikawa T, Nakamura
S, Shimizu K, Ueno Y, Tomita M and Soga T: Depiction of metabolome
changes in histidine-starved Escherichia coli by CE-TOFMS. Mol
Biosyst. 4:135–147. 2008. View
Article : Google Scholar
|
|
18
|
Ooga T, Sato H, Nagashima A, Sasaki K,
Tomita M, Soga T and Ohashi Y: Metabolomic anatomy of an animal
model revealing homeostatic imbalances in dyslipidaemia. Mol
Biosyst. 7:1217–1223. 2011. View Article : Google Scholar
|
|
19
|
Sugimoto M, Wong DT, Hirayama A, Soga T
and Tomita M: Capillary electrophoresis mass spectrometry-based
saliva metab-olomics identified oral, breast and pancreatic
cancer-specific profiles. Metabolomics. 6:78–95. 2010. View Article : Google Scholar
|
|
20
|
Junker BH, Klukas C and Schreiber F:
VANTED: A system for advanced data analysis and visualization in
the context of biological networks. BMC bioinformatics. 7:1092006.
View Article : Google Scholar
|
|
21
|
Kawamura T, Kusakabe T, Sugino T, Watanabe
K, Fukuda T, Nashimoto A, Honma K and Suzuki T: Expression of
glucose transporter-1 in human gastric carcinoma: Association with
tumor aggressiveness, metastasis, and patient survival. Cancer.
92:634–641. 2001. View Article : Google Scholar
|
|
22
|
Hamabe A, Yamamoto H, Konno M, Uemura M,
Nishimura J, Hata T, Takemasa I, Mizushima T, Nishida N, Kawamoto
K, et al: Combined evaluation of hexokinase 2 and phosphorylated
pyruvate dehydrogenase-E1α in invasive front lesions of colorectal
tumors predicts cancer metabolism and patient prognosis. Cancer
Sci. 105:1100–1108. 2014. View Article : Google Scholar
|
|
23
|
Fukuda S, Miyata H, Miyazaki Y, Makino T,
Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori
M, et al: Pyruvate kinase M2 modulates esophageal squamous cell
carcinoma chemotherapy response by regulating the pentose phosphate
pathway. Ann Surg Oncol. 22(Suppl 3): S1461–S1468. 2015. View Article : Google Scholar
|
|
24
|
Hockel M, Schlenger K, Aral B, Mitze M,
Schaffer U and Vaupel P: Association between tumor hypoxia and
malignant progression in advanced cancer of the uterine cervix.
Cancer Res. 56:4509–4515. 1996.
|
|
25
|
Payen VL, Porporato PE, Baselet B and
Sonveaux P: Metabolic changes associated with tumor metastasis,
part 1: Tumor pH, glycolysis and the pentose phosphate pathway.
Cell Mol Life Sci. 73:1333–1348. 2016. View Article : Google Scholar
|
|
26
|
Porporato PE, Payen VL, Baselet B and
Sonveaux P: Metabolic changes associated with tumor metastasis,
part 2: Mitochondria, lipid and amino acid metabolism. Cell Mol
Life Sci. 73:1349–1363. 2016. View Article : Google Scholar
|
|
27
|
Jin H, Qiao F, Chen L, Lu C, Xu L and Gao
X: Serum metabolomic signatures of lymph node metastasis of
esophageal squamous cell carcinoma. J Proteome Res. 13:4091–4103.
2014. View Article : Google Scholar
|
|
28
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar
|
|
29
|
Honjo H, Kaira K, Miyazaki T, Yokobori T,
Kanai Y, Nagamori S, Oyama T, Asao T and Kuwano H:
Clinicopathological significance of LAT1 and ASCT2 in patients with
surgically resected esophageal squamous cell carcinoma. J Surg
Oncol. 113:381–389. 2016. View Article : Google Scholar
|
|
30
|
Kobayashi H, Ishii Y and Takayama T:
Expression of L-type amino acid transporter 1 (LAT1) in esophageal
carcinoma. J Surg Oncol. 90:233–238. 2005. View Article : Google Scholar
|
|
31
|
Younes M, Pathak M, Finnie D, Sifers RN,
Liu Y and Schwartz MR: Expression of the neutral amino acids
transporter ASCT1 in esophageal carcinomas. Anticancer Res.
20:3775–3779. 2000.
|
|
32
|
Morselli E, Galluzzi L, Kepp O, Vicencio
JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor
functions of autophagy. Biochim Biophys Acta. 1793:1524–1532. 2009.
View Article : Google Scholar
|
|
33
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar
|
|
34
|
Tsun ZY and Possemato R: Amino acid
management in cancer. Semin Cell Dev Biol. 43:22–32. 2015.
View Article : Google Scholar
|
|
35
|
Pavlides S, Whitaker-Menezes D,
Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro
MC, Wang C, Fortina P, Addya S, et al: The reverse Warburg effect:
Aerobic glycolysis in cancer associated fibroblasts and the tumor
stroma. Cell Cycle. 8:3984–4001. 2009. View Article : Google Scholar
|
|
36
|
Sotgia F, Whitaker-Menezes D,
Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK,
Howell A, Philp NJ, Pestell RG and Lisanti MP: Mitochondrial
metabolism in cancer metastasis: Visualizing tumor cell
mitochondria and the ‘reverse Warburg effect’ in positive lymph
node tissue. Cell Cycle. 11:1445–1454. 2012. View Article : Google Scholar
|
|
37
|
Orrenius S: Reactive oxygen species in
mitochondria-mediated cell death. Drug Metab Rev. 39:443–455. 2007.
View Article : Google Scholar
|
|
38
|
Benahmed MA, Elbayed K, Daubeuf F,
Santelmo N, Frossard N and Namer IJ: NMR HRMAS spectroscopy of lung
biopsy samples: Comparison study between human, pig, rat, and mouse
metabolomics. Magn Reson Med. 71:35–43. 2014. View Article : Google Scholar
|
|
39
|
Li M, Song Y, Cho N, Chang JM, Koo HR, Yi
A, Kim H, Park S and Moon WK: An HR-MAS MR metabolomics study on
breast tissues obtained with core needle biopsy. PLoS One.
6:e255632011. View Article : Google Scholar
|
|
40
|
Choi JS, Baek HM, Kim S, Kim MJ, Youk JH,
Moon HJ, Kim EK and Nam YK: Magnetic resonance metabolic profiling
of breast cancer tissue obtained with core needle biopsy for
predicting pathologic response to neoadjuvant chemotherapy. PLoS
One. 8:e838662013. View Article : Google Scholar
|
